Navigation Links
Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
Date:3/27/2008

is a winning combination for Modigene and its shareholders," said Avri Havron, CEO of Modigene. "It provides the company with an immediate $2 million in cash and an option to borrow up to another $10 million at very attractive terms. We believe that Modigene's current cash position, our anticipated cash grants from the Israeli government for our human growth hormone program and the option for a $10 million five-year loan provide us with a robust capital structure. We anticipate that these resources will be sufficient to enable us to complete Phase II clinical studies for our two most advanced long-acting protein therapeutics and also provide us with at least three years of operating cash."

The line of credit extended by The Frost Group is initially for a one-year period. If Modigene draws down cash from the line of credit during the one-year period, Modigene will issue to The Frost Group 1.5 million warrants to purchase unregistered common stock of the company. The warrants have a five-year term and a $0.99 exercise price. Although the line of credit is secured, the intellectual property of the company is not part of any lien or security provided to The Frost Group under the line of credit.

"The attractive terms of this financing further demonstrate the strong commitment of the Frost investor group to Modigene," added Mr. Havron. "The structure of the transaction is well-aligned with the interests of all our shareholders. We view the option to borrow up to $10 million at favorable terms an important strategic advantage for a preclinical stage biotechnology company such as Modigene, providing management and our shareholders with the flexibility of significant potential leverage."

For more information on the financing, visit the SEC filings link at our website at http://www.modigeneinc.com.

Modigene's technology is based on a short amino acid sequence, the carboxyl terminal peptide (CT
'/>"/>

SOURCE Modigene Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. Modigene to Present at the Roth 2007 New York Investor Conference
3. GeneNews announces 2007 year end results
4. China Pharma Holdings, Inc. Announces Earnings Call for Fiscal 2007 Financial Results
5. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
6. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
7. Vicus Therapeutics Announces Participation at 15th International Molecular Medicine Tri-Conference
8. Environmental Power Announces Opening of New Corporate Headquarters in Tarrytown, NY
9. Boston Scientific Announces Schedule for ACC 2008
10. China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan
11. Medivation Announces Senior Management Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... electricity, to move data would consume much less ... concern as chips, transistor counts rise. , Of ... light emitters, modulators, and detectors emitters are ... for optical chips is molybdenum disulfide (MoS2), which ... single, atom-thick layer. Other experimental on-chip light emitters ...
(Date:9/19/2014)...  Nektar Therapeutics (NASDAQ: NKTR ) ... analgesic profiles of a series of the company,s ... The preclinical research candidates were created using Nektar,s ... The analgesic properties of kappa receptor agonism are ... Kappa opioid receptors are expressed in the peripheral ...
(Date:9/19/2014)... September 19, 2014 Cereal grain ... industries will gather October 5–8, 2014, for the ... Island Convention Center in Providence, Rhode Island. The ... work of food scientists, chemists, microbiologists, nutritionists, and ... food production management. To date, 1,000 attendees have ...
(Date:9/18/2014)... Washington, USA (PRWEB) September 18, 2014 ... Representatives of a bill designed to stimulate development and ... jobs is being praised by leaders of SPIE, ... bill, the Revitalizing American Manufacturing and Innovation (RAMI) Act, ... The bill’s authors have said they are optimistic that ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3
... KBI Biopharma, Inc. (KBI) announced today that it ... with Crucell,s PER.C6(R) human cell line platform, pursuant to ... 6, 2009. Under that agreement, KBI joins the Vendor ... for licensees of the PER.C6(R) cell lines. , ...
... International Products Corporation,s ( http://www.ipcol.com ) ... membrane compatibility and performance studies using a versatile ... any type of membrane media, from UF to RO, and ... "Our goal is to be able to recommend the most ...
... Release Highlights, - Melogliptin continues to demonstrate potential to ... low incidence of, hypoglycemia and neutral effect on ... by end 2009, - IND approved by USFDA, ... Indian company to have a truly global innovative drug for ...
Cached Biology Technology:KBI Biopharma Starts Cell Line Generation Process under Vendor Network Agreement for PER.C6(R) 2International Products Corp.'s Lab Offers Filter Membrane Compatibility and Studies 2Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials 2
(Date:9/21/2014)... developed a protein therapy that disrupts the process that ... sites, travel through the blood stream and start aggressive ... known as metastasis, can cause cancer to spread with ... succumb to cancer fall prey to metastatic forms of ... bioengineering who describes a new therapeutic approach in ...
(Date:9/19/2014)... fairness did not evolve for the sake of fairness ... of continued cooperation, so say Frans de Waal, PhD, ... about inequity aversion (IA), which is defined as a ... in Science . , Their conclusion comes ... to address their hypothesis that it is the evolution ...
(Date:9/18/2014)... A new GSA Bulletin study uses ... Rio Puerco and Chaco Wash in northern New Mexico, ... salt cedar and willow, investigators were able to precisely ... They then combined this data with aerial imagery, LiDAR, ... of these arroyos. , Arroyos are deep, oversized channels ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7
... as to how HIV evades the human immune system ... The findings suggest some HIV vaccines may have failed ... patient's own immune system is programmed to destroy. , ... which recognize and latch onto the HIV protein gp41, ...
... Africa, where days of heavy rains and flooding have led ... are reporting an unprecedented rise in Somalia's Shabelle River and ... centre of the country, the United Nations said today. , ... Affairs (OCHA), reports yesterday from Belet Weyne, close to the ...
... to recover in adolescent females once they stop using ... a study funded by the National Institute of Child ... Health. , Previous studies had shown that women who ... a loss of bone mineral density during the time ...
Cached Biology News:New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 2New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines 3Bone Density Recovers After Teens Stop Injected Contraceptive 2Bone Density Recovers After Teens Stop Injected Contraceptive 3
Application: For use as a carrier in nucleic acid purification and precipitation. Physical form: Solution in 10 mM Tris HCl, pH 7.4, 1 mM EDTA Concentration: 9-11 mg/mL Physical Form: buffered aqu...
... for calibrating single-channel and multi-channel pipettes. ,Thanks ... carrying case, the MCP1-S is ideal for ... on-site at the users premises. The unit ... individual channels are tested automatically. Multi-channel pipettes ...
... ChIP-on-chip Microarray is specifically designed for ... DNA binding proteins by pairing chromatin ... This set delivers robust hybridization and ... binding events and fewer false positives. ...
... Genome ChIP-on-chip Microarray is specifically designed ... cerevisiae) DNA binding proteins by pairing ... microarrays. This set delivers robust hybridization ... true binding events and fewer false ...
Biology Products: